Advancement of TB vaccine development in Africa necessitates national health system readiness

African research institutions are accelerating tuberculosis vaccine development, shifting the focus toward the logistical and economic challenges of deployment. The primary uncertainty remains the capacity of national health systems to secure equitable pricing and ensure widespread distribution once candidates are approved.